Chronic Kidney Disease Trial, Recruiting (NCT05726526)

Chronic Kidney Disease Trial, Recruiting NCT05726526 Sponsor: University of Manitoba Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05726526 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years of age
People whose patient or main carer can read and speak English
People whose patient or substitute decision maker is able to give informed consent to participate
People whose patient or main carer is mentally and physically able and willing to use a mobile app called VIEWER and take their own health measurements at home (such as weight and blood pressure)
People with advanced kidney disease (stage 5 chronic kidney disease), meaning two separate test results showed very low kidney function, or people whose kidneys have a greater than 40% chance of failing completely within the next 2 years based on a standard medical calculation
People who are already being seen and managed by a specialist team at a kidney disease clinic

Who may not be able to join:

People who are unable to use the VIEWER app for self-monitoring, either on their own or with the help of a carer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claudio Rigatto, MD, University of Manitoba

Phone: 204-631-3834

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05726526

Sponsor: University of Manitoba

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 204-631-3834

More information: https://clinicaltrials.gov/study/NCT05726526

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years of age
People whose patient or main carer can read and speak English
People whose patient or substitute decision maker is able to give informed consent to participate
People whose patient or main carer is mentally and physically able and willing to use a mobile app called VIEWER and take their own health measurements at home (such as weight and blood pressure)
People with advanced kidney disease (stage 5 chronic kidney disease), meaning two separate test results showed very low kidney function, or people whose kidneys have a greater than 40% chance of failing completely within the next 2 years based on a standard medical calculation
People who are already being seen and managed by a specialist team at a kidney disease clinic

Who may not be able to join:

People who are unable to use the VIEWER app for self-monitoring, either on their own or with the help of a carer

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Manitoba

Registry

ClinicalTrials.gov

Start date

30 June 2022

Est. completion

30 March 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Composite of first hospitalization or emergency department (ED) visit

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov